This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (19)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Treatment With Erythromycin

Joel S. Shavin, MD; Terry M. Jones, MD; James K. Aton, MD; Donald C. Abele, MD; J. Graham Smith, Jr, MD

Arch Dermatol. 1978;114(11):1679-1680.

Abstract
• Safe therapeutic measures for Mucha-Habermann's disease in children are lacking. Three patients with the disease were treated with erythromycin for systemic effect. Although the series is small and uncontrolled, this approach seemed effective. An anti-inflammatory mechanism related to inhibition of chemotaxis is speculated.

(Arch Dermatol 114:1679-1680, 1978)

Author Affiliations
From the Department of Dermatology, Medical College of Georgia, Augusta. Dr Shavin is now in private practice in Snellville, Ga.

Footnotes
Accepted for publication June 16, 1978.

Reprint requests to Department of Dermatology, Medical College of Georgia, Augusta, GA 30901 (Dr Abele).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Widespread Hemorrhagic and Crusted Eruption of Recent Onset
Gross et al.
Arch Dermatol 1993;129:365-366.
ABSTRACT  

Clinical and Histologic Features of Pityriasis Lichenoides et Varioliformis Acuta in Children
Longley et al.
Arch Dermatol 1987;123:1335-1339.
ABSTRACT